Dennis E. Marshall - Dec 31, 2023 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, Attorney-in-fact
Stock symbol
BLGO
Transactions as of
Dec 31, 2023
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 05:42 PM
Previous filing
Oct 3, 2023
Next filing
Apr 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award +112K +2.79% 4.11M Dec 31, 2023 Common Stock 112K $0.17 Direct F1
transaction BLGO Option to Purchase Common Stock Award +134K +3.33% 4.15M Dec 31, 2023 Common Stock 134K $0.17 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.
F2 This Option was granted to Reporting Person to replace an option to purchase 90,000 shares that had been issued December 31, 2013 to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
F3 Total reflects the expiration of options to purchase 90,000 shares that expired on December 31, 2023.